http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105079062-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-258 |
| filingDate | 2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105079062-B |
| titleOfInvention | A kind of soft capsule for removing thromboembolism and preparation method thereof and detection method |
| abstract | The invention discloses a kind of soft capsule for removing thromboembolism and preparation method thereof and detection methods, belong to technical field of medicine.Every 330mg containing content of the soft capsule, wherein arasaponin contain 60mg, remaining is pharmaceutic adjuvant；Contain Panax Notoginseng saponin R in the arasaponin 1 3.0~5.0mg, ginsenoside Rg 1 15.0~20.0mg, ginsenoside Rb 1 15.0~20.0mg, 1.5~4.5mg of ginsenoside Re, 3.0~5.0mg of ginsenoside Rd, and the total amount of above-mentioned five kinds of saponin(es are 45~50mg.It is an advantage of the invention that：The soft capsule when being detected, more stablize, be controllable by testing result. |
| priorityDate | 2015-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 54.